Vida Ventures Advisors, LLC
- SEC CIK
- 0001831423
- Latest filing
- Nov 3, 2025
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Jul 19, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 7
- 0 vs. Q1 2023
- Portfolio value
- $76.6M
- +$3.50M (+4.8%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DYNDyne Therapeutics, Inc. | COM | 2,220,034 | $25.0M | 32.6% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 3,931,818 | $24.3M | 31.8% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 1,798,163 | $8.94M | 11.7% | 00.0% | Unchanged | History |
| KNTEKinnate Biopharma Inc. | COM | 2,207,772 | $6.69M | 8.7% | 00.0% | Unchanged | History |
| LIANYLianBio | SPONSORED ADS | 2,282,084 | $5.20M | 6.8% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 2,765,314 | $4.76M | 6.2% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,469,665 | $1.69M | 2.2% | 00.0% | Unchanged | History |